Lung cancer Posts on Medivizor
Navigation Menu

Lung cancer Posts on Medivizor

Does a high level of white blood cells before surgery impact outcome in patients with lung cancer

Posted by on Nov 7, 2018 in Lung cancer | 0 comments

In a nutshell This study wanted to find out if having a high number of a particular white blood cell before surgery was related to a worse outcome in patients with lung cancer. The study found that having a high number of white blood cells before surgery was related to a worse outcome after surgery. Some background White blood cells are the cells of...

Read More

Is there a link between radiation therapy and future heart problems in patients with small-cell lung cancer?

Posted by on Oct 20, 2018 in Lung cancer | 0 comments

In a nutshell This study looked at the link between cardiac (heart) events in the years after radiation therapy in patients with small-cell lung cancer. The authors concluded that there is a long-term risk of cardiac events in patients treated with a combination of radiation therapy and chemotherapy. Some background There have been several reports...

Read More

Comparing different chemotherapy combinations to improve treatment of extensive-stage small cell lung cancer

Posted by on Sep 28, 2018 in Lung cancer | 0 comments

In a nutshell This study looked at a combination of irinotecan (Camptosar) and platinum-based drugs, for treating patients with extensive-stage small cell lung cancer. The authors concluded that this combination has the potential to improve the outcomes for these patients.   Some background Extensive stage small-cell lung cancer (ES-SCLC) is...

Read More

Which chemotherapy drugs are better after surgery for patients with NSCLC?

Posted by on Sep 28, 2018 in Lung cancer | 0 comments

In a nutshell This study evaluated the effectiveness of fluorouracil (Adrucil) chemotherapy after surgery in patients with non-small-cell lung cancer (NSCLC). The authors concluded that treatment with fluorouracil resulted in prolonged recurrence-free survival compared to standard chemotherapy regimens. Some background Adjuvant therapy is given in...

Read More

The link between time to disease progression and survival after progression in patients with advanced lung cancer

Posted by on Sep 18, 2018 in Lung cancer | 0 comments

In a nutshell This study looked at a link between time to disease progression and longer survival after progression in patients with advanced BRAF V600E non-small-cell lung cancer. The authors concluded that a longer time to disease progression after treatment was linked to longer survival in these patients.  Some background Some non-small-cell...

Read More

“Your Life Depends on Your Own Advocacy”

“Your Life Depends on Your Own Advocacy”

Posted by on Sep 10, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 1 comment

“Always trust your gut. Don’t leave your treatment in the hands of someone that you don’t trust or that does not seem like a team player. Yes, they are all smart—even brilliant—but read, read, read, and question them at every corner and challenge the standard of care. Exercise, healthy eating, learning the ropes of insurance, mediation/prayer...

Read More

Does the frequency of surveillance after surgery impact survival in patients with NSCLC?

Posted by on Sep 2, 2018 in Lung cancer | 0 comments

In a nutshell This study looked at the frequency of follow-ups after surgical treatment in patients with non-small-cell lung cancer and whether it had an effect on survival. The study concluded that more frequent surveillance was not linked to improved survival.  Some background Surveillance during the post-treatment stage of cancer is a critical...

Read More

Clinical Trials Today

Clinical Trials Today

Posted by on Aug 26, 2018 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Erectile dysfunction, Hodgkin's lymphoma, Hypertension, Infertility, Kidney stones, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Nocturia, Non-Hodgkin lymphoma, Overactive bladder, Parkinson's Disease, Prostate cancer, Rheumatoid Arthritis, Stroke, Urinary incontinence, Urinary tract infection | 4 comments

Prior to the 20th century, most people lived about 47 years in the developed world because of infectious diseases. In 1940, the first use of penicillin to treat infectious diseases occurred and penicillin became available in 1945 to the general public. Science and research conducted throughout the 1950s, 60s, and 70s, created more antibiotics so that life...

Read More

Comparing the effectiveness of different immunotherapy drugs for patients with NSCLC

Posted by on Aug 21, 2018 in Lung cancer | 0 comments

In a nutshell This study looked at three different immune checkpoint inhibitors and how effective they were at treating patients with non-small-cell lung cancers (NSCLC) with different levels of PD-L1 protein. The authors found that all three drugs analyzed were more effective than chemotherapy for these patients. Some background Many tumor cells have...

Read More

Cancer Vaccines

Cancer Vaccines

Posted by on Aug 13, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 4 comments

When I think of vaccines, I think of the MMRV (measles, mumps, rubella and varicella) vaccines which help our bodies establish immunity against diseases that used to kill.  Now, there are vaccines being created for cancer. The rise of cancer vaccines According to Dr. Nora Disis, an oncologist and researcher in cancer vaccines at the University of...

Read More